Want to see HK:1875 full AI Analyst Report?
TOT BIOPHARM International Co. Ltd. (1875) Stock Forecast & Price Target
1875 Analyst Ratings
There are no analyst ratings in the last 3 months.
1875 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Shang | Jefferies | HKD 4.40 | buy | 32.93%Upside | Reiterated | 06/08/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| David Shang | 06/08/26 | HKD 4.40 | buy | 32.93%Upside | Reiterated | Jefferies |
Best Analysts Covering TOT BIOPHARM International Co. Ltd.
Copying David Shang's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.70% per trade.
Copying David Shang's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -5.40% per trade.
Copying David Shang's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -5.40% per trade.
1875 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, 1875 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1875 average Analyst price target in the past 3 months is ―.
1875 Financial Forecast
1875 Earnings Forecast
Next quarter’s earnings estimate for 1875 is -HKD 0.09 with a range of ― to ―. The previous quarter’s EPS was -HKD 0.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
1875 Sales Forecast
Next quarter’s sales forecast for 1875 is HKD 280.45M with a range of ― to ―. The previous quarter’s sales results were HKD 280.45M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.